Statutory Committee inquiries
The Statutory Committee will meet at the Royal Pharmaceutical Society of Great Britain, 1 Lambeth High Street, London SE1, at 9.30am on Monday 22 January, Tuesday 23 January and Wednesday 24 January 2007 to hear the following matters:
1. The committee will hear an application for restoration to the Register
from Hasmukhkant Nanji Badiani. Mr Badiani’s name was removed from
the Register in May 2003 following a direction of the Statutory Committee.
2. The committee will hear the new inquiry into a complaint by the Council
of the Society against Anilkumar Ishverbhai Patel (registration number 70633)
and Hemantika Anil Patel (registration number 71179), which alleges that: the
alteration of the dosage instructions for a patient without seeking the prescriber’s
authorisation; the making of a deliberately false record in the pharmacy diary
of a conversation with a doctor; the failure to take proper or sufficient steps
in response to an enquiry from the above patient’s mother regarding the
change of dosage; a number of dispensing errors; the failure to take proper
or sufficient steps in response to dispensing errors; deliberately misleading
a patient regarding the cause of the dispensing errors; deliberately making
a false entry in the pharmacy diary in relation to the above; a number of labelling
errors; the supply of a Controlled Drug other than in accordance with the Misuse
of Drugs Regulations 2001; a failure to supply Piriton syrup without an explanation
and misleading a patient with regards to this failed supply; an attempt to
persuade a patient to accept Lantus insulin cartridges in place of the Lantus
insulin vials prescribed; the failure to supply the correct quantity of medication
in circumstances where no owing slip was supplied; the making of inaccurate
records in the patient medication record; a failure to have adequate systems
in the pharmacy; the pharmacy’s supply of sugar-free methadone in response
to prescriptions calling for methadone; a failure to heed the advice of the
Society’s inspector in relation to extemporaneous production of methadone
and in relation to the use of medicinal products that did not bear any marketing
authorisation; the dispensing of unlicensed senna; the failure to ensure that
dates of opening were recorded on medication with limited shelf-life; the failure
to ensure the application of a system to minimise the risk of dispensing errors;
the presence in the dispensary of loose capsules, loose and cut blister strips
and capsules of unknown provenance, and a failure to heed the advice of the
Society’s inspector in this regard; the presence in the dispensary of
manufacturers’ boxes containing strips of tablets and capsules some of
which had no batch numbers and/or expiry dates; the presence in the dispensary
of manufacturers’ boxes containing strips of tablets and capsules of
a brand differing from those marked on the manufacturer’s box and a failure
to heed the advice of the Society’s inspector in relation to the above;
and the presence in the storage area of empty medicine bottles available for
use which were uncapped and vulnerable to contamination, may amount to misconduct.
In relation to Mr Patel, the Society’s Council also alleges that the
failure to comply with the condition of the Statutory Committee and/or his
undertaking to the Committee that he would not be in control of a pharmacy,
nor have control for stock control at a pharmacy, may amount to misconduct.
David Gomez
Secretary to the Statutory Committee |
The
Pharmaceutical Journal